Marinobufagenin and ouabain effectively inhibit Na,K-ATPase containing ouabain-sensitive -isoform at concentrations of 2.0 and 0.8 M, respectively (Tverskoi et al., 2021)
Options include pausing dose increases, switching to oral semaglutide, reducing to the microdose GLP-1 protocol ($129/month), or trying the Precision Peptide Genetic Test to guide a personalized medication change
It tells the pituitary gland, "Hey, stop releasing growth hormone right now." So, picture this
Follow Aqua Medical for ongoing updates as we continue to evaluate safety, durability, and outcomes in larger trials
[25] NAD+ repletion restored NAD+ metabolic profiles, improved fat metabolism, lowered mitochondrial oxidative stress, and improved mitochondrial integrity in human cells with mutant WRN via restoring normal mitophagy
You already manage metabolic monitoring for antipsychotics (glucose, lipids)